The dietary sodium recommendation by the Institute of Medicine is intended as a `one size fits all' recommendation, but it is becoming clear that each individual is genetically programmed with a personal index of salt sensitivity' and dietary salt (NaCl) consumption guidelines should be personalized. The kidney is a key, but not exclusive, regulator of sodium balance. Within the kidney the anti-natriuretic (sodium retaining) angiotensin type 1 receptor (AT1R) is a dominant regulator of blood pressure homeostasis under conditions of low and normal sodium intake. However, with moderate increase in sodium intake the D1-like dopamine receptors (D1 receptor (D1R) and D5 receptor (D5R)) in conjunction with the angiotensin type 2 receptor (AT2R) exert important counter regulatory natriuretic roles. These counter regulatory processes and end effectors become unbalanced in the presence of variant genes, including those regulating the activity of receptors (such as the G protein-coupled kinase type 4 (GRK4)), second messengers, ion transporters (e.g., sodium bicarbonate cotransporters), and ion exchangers and pumps. This PPG will test the hypothesis that the electrogenic sodium bicarbonate cotransporter NBCe2 (coded by the gene SLC4A5) and GRK4 variant 65L are involved in the etiology of salt sensitivity, a condition affecting 51% of hypertensives and 26% of normotensives. The hypothesis is based on genetic data demonstrating a strong association between variants in SCL4A5 and GRK4-65L and salt sensitivity, as well as preliminary data showing a renal dopaminergic and angiotensin system imbalance and aberrant expression and activity of NBCe2 and the chloride bicarbonate exchanger putative anion exchanger 1 (PAT-1). We will test our hypothesis using human renal proximal and distal tubule cells to examine receptors, transporters, and epigenetic regulatory mechanisms (Project 1). Project 3 will use genetically modified rodents to study the physiology of the same receptors, transporters, and epigenetic pathways as Project 1. Finally, Project 2 will perform in human subjects, expressing various genotypes of SLC4A5 and GRK4, electrolyte balance studies under various manipulations of sodium balance and the dopaminergic and renin-angiotensin systems. This Program Project will yield a thorough understanding of salt sensitivity that affects up to 34% of 58 million Americans.

Public Health Relevance

Overall Narrative Although the dietary sodium recommendation by the Institute for Medicine is intended as a `one size fits all' recommendation, it is becoming clear that each individual is genetically programmed with a `personal index of salt sensitivity' and dietary salt (NaCl) consumption guidelines should be personalized. Salt intake and cardiovascular morbidity and mortality have a J-shaped curve relationship, in that both a low-salt diet as well as a high-salt diet may be associated with increased risk for stroke, kidney failure, blindness, and heart attack. More research is needed to understand the nonlinear and personalized effect of salt intake on cardiovascular disease and death.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL074940-15
Application #
9949757
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
OH, Youngsuk
Project Start
2004-04-01
Project End
2021-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
15
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Virginia
Department
Pathology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Muntner, Paul; Whelton, Paul K; Woodward, Mark et al. (2018) A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes. Diabetes Care 41:2322-2329
Ye, Zhengmeng; Lu, Xi; Deng, Yi et al. (2018) In Utero Exposure to Fine Particulate Matter Causes Hypertension Due to Impaired Renal Dopamine D1 Receptor in Offspring. Cell Physiol Biochem 46:148-159
Yang, Yang; Chen, Caiyu; Fu, Chunjiang et al. (2018) Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells. J Am Soc Hypertens 12:135-145
Li, Fengmin; Yang, Jian; Villar, Van Anthony M et al. (2018) Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice. Diabetologia 61:727-737
Wang, Xiaoyan; Villar, Van Anthony; Tiu, Andrew et al. (2018) Dopamine D2 receptor upregulates leptin and IL-6 in adipocytes. J Lipid Res 59:607-614
Luo, Hao; Chen, Caiyu; Guo, Li et al. (2018) Exposure to Maternal Diabetes Mellitus Causes Renal Dopamine D1 Receptor Dysfunction and Hypertension in Adult Rat Offspring. Hypertension 72:962-970
Wu, Gengze; Jose, Pedro A; Zeng, Chunyu (2018) Noncoding RNAs in the Regulatory Network of Hypertension. Hypertension 72:1047-1059
Asico, Laureano D; Cuevas, Santiago; Ma, Xiaobo et al. (2018) Nephron segment-specific gene expression using AAV vectors. Biochem Biophys Res Commun 497:19-24
Tiu, Andrew C; Bishop, Michael D; Asico, Laureano D et al. (2017) Primary Pediatric Hypertension: Current Understanding and Emerging Concepts. Curr Hypertens Rep 19:70
Diao, Zhenyu; Asico, Laureano D; Villar, Van Anthony M et al. (2017) Increased renal oxidative stress in salt-sensitive human GRK4?486V transgenic mice. Free Radic Biol Med 106:80-90

Showing the most recent 10 out of 123 publications